Growth hormone (GH) gene expression has been examined in control and transgenic coho salmon contain ing a transgene comprised of the sockeye salmon GH1 gene under the control of the MT-B promoter from the same species. This transgene dramatically enhances the growth of salmonids, and raises serum GH levels some forty-fold. Transcript levels from this transgene were detected by RT-PCR in all tissues exam ined, and an obvious increase of the transgene expression was obtained in some developing stage. GH mRNA levels were also examined in the pituitary gland, and were found to be significantly lower (p<0.01) in transgenic compared to nontransgenic salmon of the same size. Pituitary glands of transgenic were also smaller than control of the same size. The transgenic fish changed a surface area in the anterior intestine, and the intestine of GH transgenic salmon had more folds and the path tracing the inner circumference around the intestinal folds of a cross section was about 2.7 times longer than in control salmon. Further, the transgenic salmon increased ability to compete for food, and they consumed 2.9 times more pellets that the non-transgenic controls.
INTRODUCTION
Since the production of growth-enhanced transgenic mice in the early 1980s, transgenic techniques have been used extensively to study the effects of growth hormone (GH) overexpression in various mammalian systems1). This work also stimulated the development of gene transfer methods for several fish species, both for the development of lower vertebrate model systems and to enhance production characteristics for species grown in aquaculture2). The majority of these experiments with fish have involved the transfer of GH gene constructs of both mammalian and piscine origin, and currently have involved over a dozen fish species3).
The phenotypic effects of GH transgenes in mammals and most fish species has ranged from no effect to approximately a doubling of body size4). In contrast, salmonids appear particularly responsive to growth stimulation by somatotropins when administered either by intraperitoneal injection or by transgenesis. For transgenesis, very dramatic growth effects can be observed, typically between 6 and 11-fold but ranging to as much as 37 fold relative to controls5) in several salmonid species. The different responses may arise from the gene constructs utilized: The effects seen in salmonids were obtained with constructs derived from fish DNA, whereas mammalian GH transgenes have not yet produced dramatic phenotypic effects in fish6). The present report examines the expression of the salmon transgene OnMTGH15) (the sockeye salmon metallothionein-B promoter fused to the type-1 growth hormone gene from the same species) in transgenic coho salmon tissues at different developmental stages. Since GH is a multifunctional hormones, feeding behavior and anatomical differences of digestive organs in GH transgenic salmon was also investigated. Size-matched transgenic and control salmon were killed with an overdose of anaesthetic and measured. They were injected with buffered formalin, fastened to a wooden tongue depressor with elastics to keep the body straight, then placed in buffered formalin and send to the laboratory in Guelph. All gastrointestinal tract measure ments were described in Stevens et al12).
Statistical analysis
Values for mRNA are expressed as means +/-SE. The statistical significance was determined by one-way anal ysis of variance followed by a posteriori comparisons on the significant ANOVA results using Fisher PLSD. Sta tistical significance was set at p< 0.05.
RESULTS

OnMTGH1 transgene expression in various tissues
The pattern of OnMTGH1 transgene expression in vari ous tissues was examined by northern hybridization. High-level expression was observed in spleen, pyloric caeca, kidney, and intestine, and smaller amounts were detectable in skin and gill, stomach and liver. GH mRNA was not detected in muscle. The GH mRNA from the transgene was similar in size to the endogenous GH produced in control pituitaries. Primers were designed that could amplify sequences from the sockeye GH1 present in the transgene construct but were not capable of amplifying host (coho) GH1 or GH2 sequenc es. Analysis of two sizes of transgenic fish by RT-PCR revealed that transgene mRNA could be detected in all tissues examined. As was observed with the northern analysis, a single band was observed from all tissues. The GH bands amplified by RT-PCR were directly sequenced, revealing that they were indeed derived from the transgene.
Quantitation of transgene expression
OnMTGH1 transcripts from different tissues of transgenic fry (3.5-4.0cm in FL, 0.5-1.0g in WT) and from large transgenics (40-47cm in FL, 1.2-1.7kg in WT) were quantitated by RNA dot blot analysis. The highest level of OnMTGH1 transgene mRNA was observed in pyloric caeca, followed in descending order kidney, spleen, intestine, skin, stomach, liver, and muscle. Lev els of mRNA in pyloric caeca were significantly (p<0.05) greater than that of the other tissues. Not all tissues could be obtained from transgenic fry, and even in those analyzed (skin, intestine, and muscle), it was dif ficult to detect GH mRNA suggesting that transcription of the transgene may be lower in very early development, high during the early juvenile growth phase, and then reduced in older larger animals. For each fish of the 12 pairs, food consumption during the repeated feeding trials was first summarized for each of the 30 sequentially presented pellets.
As there were six feeding trials, a fish in a pair could theoretically con sume a maximum of six pellets for any of the sequential pellets given. Analysis of the food consumption at the initiation of feeding showed that the transgenic fish took these significantly more often than the control fish. The initial consumption of the transgenic fish was 2.5 times that of the control fish. While the consumption declined gradually in a near-linear fashion for both the transgenic and the control fish during continued feeding. Thus, the transgenic fish consumed 50.3 pellets on average, or about 2.9 times more food than the control fish.
Intestinal morphology in transgenic salmon
Length of the anterior and posterior intestine, and total intestine length did not differ between transgenic and size-matched control. The anterior intestine of GH transgenic salmon had more folds and the path tracing the inner circumference around the intestinal folds of a cross section was about 2.7 times longer than in control salmon. The product of the inner circumference and the length of the anterior intestine were used to estimate the total anterior intestinal surface area. This was 2.4 times greater in GH transgenic salmon than in control salmon. The inner circumference and surface area of the posterior intestine while greater in GH transgenic salmon were not statistically different. The total surface area (anterior plus posterior) was 2.2 times larger in GH transgenic salmon than in control salmon.
DISCUSSION
Mammalian MT promoters have also been used to drive GH gene expression in transgenic fish, and effects on growth have been noted. Further, the mammalian MT promoter has been shown to be active in transient assays in fish cells and microinjected fish embryos. Mice containing GH transgenes have elevated plasma GH, and grow to almost twice the size of their normal litter mates. In such mice, endogenous GH synthesis is inhibited due to negative feedback regulation by high serum GH and IGF-I levels 13), and abnormal pituitary development ensues, with a dramatic reduction of acido philic or GH producing cells detected by immuno cyto chemistry. Interestingly, GH gene constructs containing different promoters affect somatotrophs differently in transgenic mice; for example, pituitary GH mRNA levels were reduced approximately 38% and 98% in MT-bGH and PEPCK-bGH transgenic mice, respectively14). Stefaneanu et al 15) demonstrated significantly decreased pituitary mass and GH mRNA levels in GH transgenic mice pituitary relative to controls, indicating that nega tive feedback may be occurring. We have observed simi lar effects on GHmRNA and pituitary size in transgenic fish containing the OnMTGH1 transgene, indicating that such regulatory mechanisms controlling GH expression are also operating in lower vertebrates. (and perhaps also Gill at even lower levels), and whether functional protein is being produced, secreted, and acting in a paracrine or endocrine fashion.
The elevated competitive food consumption and growth rate of GH transgenic salmon measured in the present study is consistent with the known physiological functions of GH in salmonids. The data are also consis tent with the hypothesis that GH increases feeding moti vation and appetite in salmonids.
As the strain of GH transgenic fish used in this study has been shown to have extraordinarily high plasma GH levels. It can be assumed that the observed differences between the transgenic and non-transgenic fish are GH mediated, and that GH transgenesis and GH treatment thus appear to induce similar changes in the feeding behavior of salmonids.
While, the strong appetite of the transgenic salmon and extraordinary growth performance were reflected in the gastrointestinal tract. The surface area of intestine was significantly greater in GH transgenic salm on due to the increased size and numbers of intestinal folds. This suggesting that GH could stimulate appetite and some aspect of this stimulus could induce indirect changes in intestine morphology or GH could have a direct effect on intestinal growth. GH is one of the most multifunctional hormones, therefore this might be stimulateing growth performance through more compli cated systems than we imagined.
